CannAmerica Brands Corp (CNNXF)
0.00
USD |
OTCM |
May 31, 16:00
CannAmerica Brands Max Drawdown (5Y): 100.00% for May 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
May 31, 2024 | 100.00% |
April 30, 2024 | 100.00% |
March 31, 2024 | 100.00% |
February 29, 2024 | 100.00% |
January 31, 2024 | 100.00% |
December 31, 2023 | 100.00% |
November 30, 2023 | 100.00% |
October 31, 2023 | 100.00% |
September 30, 2023 | 100.00% |
August 31, 2023 | 100.00% |
July 31, 2023 | 100.00% |
June 30, 2023 | 100.00% |
May 31, 2023 | 99.76% |
April 30, 2023 | 99.76% |
March 31, 2023 | 99.76% |
February 28, 2023 | 99.76% |
January 31, 2023 | 99.76% |
December 31, 2022 | 99.76% |
November 30, 2022 | 99.69% |
October 31, 2022 | 99.69% |
September 30, 2022 | 99.59% |
August 31, 2022 | 99.53% |
July 31, 2022 | 99.53% |
June 30, 2022 | 99.53% |
May 31, 2022 | 99.53% |
Date | Value |
---|---|
April 30, 2022 | 99.53% |
March 31, 2022 | 99.53% |
February 28, 2022 | 99.53% |
January 31, 2022 | 99.53% |
December 31, 2021 | 99.53% |
November 30, 2021 | 99.53% |
October 31, 2021 | 99.53% |
September 30, 2021 | 99.53% |
August 31, 2021 | 99.53% |
July 31, 2021 | 99.53% |
June 30, 2021 | 99.53% |
May 31, 2021 | 99.53% |
April 30, 2021 | 99.53% |
March 31, 2021 | 99.53% |
February 28, 2021 | 99.53% |
January 31, 2021 | 99.53% |
December 31, 2020 | 99.53% |
November 30, 2020 | 99.53% |
October 31, 2020 | 99.53% |
September 30, 2020 | 99.53% |
August 31, 2020 | 99.53% |
July 31, 2020 | 99.53% |
June 30, 2020 | 99.53% |
May 31, 2020 | 99.53% |
April 30, 2020 | 99.53% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
92.67%
Minimum
Jun 2019
100.00%
Maximum
Jun 2023
99.22%
Average
99.53%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Lexaria Bioscience Corp | 98.90% |
Liminal Biosciences Inc (DELISTED) | -- |